Clinical Research

HOME > R&D Achievement > Clinical Research > Article
 
DATE : 16-03-14 13:35
Simultaneous subacute stent thrombosis of two sirolimus-eluting stents in a patient treated by ReoPro, thrombus aspiration and triple anti-platelet agents.
 WRITER : stent
HIT : 2,444  
   C73._Int_J_Cardiol._2008;130_1_e25-29..pdf (1.2M) [0] DATE : 2016-03-14 13:35:41
C73. Moon JY, Chung JW, Kim JH, Ahn YK, Jeong MH; Simultaneous subacute stent thrombosis of two sirolimus-eluting stents in a patient treated by ReoPro, thrombus aspiration and triple anti-platelet agents. Int J Cardiol. 2008;130(1)e25-29.

(Abstract)
Effective anti-platelet treatment has a key role in the prevention of stent thrombosis in the drug-eluting stent (DES) era. However, despite of the use of anti-platelet agents, stent thrombosis occurs in approximately 1% of patients, with an increased likelihood of occurrence in high-risk patients or complex lesion subset of patients [1-4]. According to the previous report, triple anti-platelet therapy (aspirin+clopidogrel+cilostazol) seemed to be more effective in preventing thrombotic complications after stenting than dual anti-platelet agent [5]. But, in this report, we present a patient with subacute stent thrombosis (ST) involving two different arteries simultaneously under the use of triple anti-platelet regimen.